ESC 365 - Differences in recommendations and associated level of evidence for statins in primary prevention of CVD according to the ACC/AHA 2013, CCS 2016, ESC 2016, and USPSTF 2016 clinical practice guidelines

ESC Premium Access

Differences in recommendations and associated level of evidence for statins in primary prevention of CVD according to the ACC/AHA 2013, CCS 2016, ESC 2016, and USPSTF 2016 clinical practice guidelines

Session: Poster session 7 - Prevention general

Topic: Epidemiology, lipids

Speaker: Doctor M. Leening (Rotterdam, NL)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Maarten Leening

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

0 follower

27 more presentations in this session

Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study

Speaker: Professor F. Saad (Berlin, DE)

Enhanced cardiovascular susceptibility to air pollution: A 4 years echocardiographic study of pulmonary circulation.

Speaker: Professor J. Argacha (Brussels, BE)

Systemic inflammatory response in chronic venous disorders and their clinical relevance in the general population.

Speaker: Doctor N. Arnold (Mainz, DE)

The hemoglobin A1C and creatinine are associated with coronary calcium score for female but not male in a general low risk population

Speaker: Doctor J. Wu (Toufen, TW)

ABCA1 gene polymorphism InsG319 prevents the development of impaired glucose tolerance in young and middle-aged women

Speaker: Professor S. Boldueva (Saint Petersburg, RU)

Access the full session

Poster session 7 - Prevention general

Speakers: Doctor M. Leening, Professor F. Saad, Professor J. Argacha, Doctor N. Arnold, Doctor J. Wu...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources